Evidence map›Paper›PMID 35379003›Full record

ArticleAmerican journal of physiology. Renal physiology2022

Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells.

Ranjit K Sahu, Sandhya Xavier, Daniel Chauss, Luopin Wang, Claude Chew, Ronald Taylor, William B Stallcup, Jennie Z Ma, Majid Kazemian, Behdad Afzali and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Role of local complement activation in kidney fibrosis and repair.The Journal of clinical investigation · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Ranjit K SahuDepartment of Medicine and Center for Immunity and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Sandhya XavierDepartment of Medicine and Center for Immunity and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.ORCID 0000-0003-1283-8962
Daniel ChaussImmunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Luopin WangDepartments of Biochemistry and Computer Science, Purdue University, West Lafayette, Indiana.
Claude ChewFlow Cytometry Core, University of Virginia, Charlottesville, Virginia.
Ronald TaylorDepartment of Biochemistry, University of Virginia, Charlottesville, Virginia.
William B StallcupSanford Burnham Prebys Medical Discovery Institute, Tumor Microenvironment and Cancer Immunology Program, La Jolla, California.
Jennie Z MaDivision of Biostatistics, Department of Public Health, University of Virginia, Charlottesville, Virginia.
Majid KazemianDepartments of Biochemistry and Computer Science, Purdue University, West Lafayette, Indiana.
Behdad AfzaliImmunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Jörg KöhlInstitute for Systemic Inflammation Research, University of Lübeck, Germany.ORCID 0000-0003-1121-3178
Didier PortillaDepartment of Medicine and Center for Immunity and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.ORCID 0000-0003-0238-1743
University of Virginia · USNational Institutes of Health · USPurdue University West Lafayette · USCincinnati Children's Hospital Medical Center · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Unravelling immunoregulatory circuits of tissue inflammationZIADK075149 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI AFZALI, BEHDAD · 2019 to 2025
$19.3M
Joint submission for administrative supplement proposal: HIPAA aligned storage and computing solutionR35GM138283 · NIGMS · PURDUE UNIVERSITY · PI KAZEMIAN, MAJID · 2020 to 2024
$2.0M
Role of intracellular complement activation in kidney fibrosisR01DK122624 · NIDDK · UNIVERSITY OF VIRGINIA · PI PORTILLA, DIDIER · 2020 to 2022
$727k
HHS | National Institutes of Health (NIH) RO1-DK-122624001A1NIDDK NIH HHS R01 DK122624NIGMS NIH HHS R35 GM138283
6 · The paper itself

Abstract

We have previously reported that increased expression and activation of kidney cell complement components play an important role in the pathogenesis of renal scarring. Here, we used floxed green fluorescent protein (GFP)-C5a receptor 1 (C5aR1) knockin mice (GFP-

Indexed as

Folic AcidReceptor, Anaphylatoxin C5aAnimalsCicatrixFibrosisGreen Fluorescent ProteinsKidneyMiceMice, KnockoutMyeloid CellsReceptors, Platelet-Derived Growth FactorFolic AcidGreen Fluorescent ProteinsReceptor, Anaphylatoxin C5aReceptors, Platelet-Derived Growth Factorcomplement C5a receptor 1fibrosismacrophagespericytesRNA sequencing

Identifiers

PMID35379003
PMCPMC9054266
OpenAlexW4225091053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.